Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes

Streptozotocin (STZ) 60 mg/kg, i.p.-induced diabetes in rat’s results into hyperglycemia, impaired oxidative stress, lipid profile, insulin levels and changes in body weight. Treatment with antihyperglycemics and antioxidants are accounted to produce favorable effect in this paradigm. Fustin, a flav...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sadaf Jamal Gilani, May Nasser Bin-Jumah, Fahad A. Al-Abbasi, Muhammad Shahid Nadeem, Muhammad Afzal, Nadeem Sayyed, Imran Kazmi
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/84c949e613dd4f4fb92da3fed84cbc74
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:84c949e613dd4f4fb92da3fed84cbc74
record_format dspace
spelling oai:doaj.org-article:84c949e613dd4f4fb92da3fed84cbc742021-11-20T04:56:33ZFustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes1319-562X10.1016/j.sjbs.2021.07.070https://doaj.org/article/84c949e613dd4f4fb92da3fed84cbc742021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1319562X21006537https://doaj.org/toc/1319-562XStreptozotocin (STZ) 60 mg/kg, i.p.-induced diabetes in rat’s results into hyperglycemia, impaired oxidative stress, lipid profile, insulin levels and changes in body weight. Treatment with antihyperglycemics and antioxidants are accounted to produce favorable effect in this paradigm. Fustin, a flavonoid derived from Rhus verniciflua, extract of Rhus verniciflua reported to exhibit anti-hyperglycemic, antioxidant, anti-microbial, anti-arthritic effects, anti-obesity effects, antiplatelet effects and anti-cancer effects. However, no evidence is existing on effect of fustin on STZ-induction diabetes. Thus, we evaluated its effects against diabetes in STZ-induced rodents. Blood glucose, Insulin, lipid peroxidation (MDA), superoxide dismutase (SOD), catalase activity (CAT), glutathione (GSH) and lipid profile levels was assessed. After 30 days diabetes induction rodents showed a severe increased blood sugar level, MDA, high density lipid and decreased cholestrol, triglyceride, GSH, SOD, CAT, respectively.Oppositely, treatment with fustin (50–100 mg/kg/p.o., two times daily, 30 days) enhanced blood glucose, lipid profile levels Insulin. Meanwhile, reduced MDA and enhanced GSH, SOD, and CAT in diabetic rats. Glibenclamide 5 mg/kg/p.o. also enhanced diabetes-induced complications and decreased oxidative stress. Further histopathology of pancreas confirms the protective effect fustin in STZ-induction diabetes in animals. In conclusion, the study revealed treatments with fustin avoid the changes in body weight, blood glucose, lipid profile and oxidative stress. As a results of these finding may lead to the growth of a choice of medicine for hyperglycemic in the future.Sadaf Jamal GilaniMay Nasser Bin-JumahFahad A. Al-AbbasiMuhammad Shahid NadeemMuhammad AfzalNadeem SayyedImran KazmiElsevierarticleBlood glucoseBody weightDiabetesFustinGlyburideLipid profileBiology (General)QH301-705.5ENSaudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 6963-6971 (2021)
institution DOAJ
collection DOAJ
language EN
topic Blood glucose
Body weight
Diabetes
Fustin
Glyburide
Lipid profile
Biology (General)
QH301-705.5
spellingShingle Blood glucose
Body weight
Diabetes
Fustin
Glyburide
Lipid profile
Biology (General)
QH301-705.5
Sadaf Jamal Gilani
May Nasser Bin-Jumah
Fahad A. Al-Abbasi
Muhammad Shahid Nadeem
Muhammad Afzal
Nadeem Sayyed
Imran Kazmi
Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes
description Streptozotocin (STZ) 60 mg/kg, i.p.-induced diabetes in rat’s results into hyperglycemia, impaired oxidative stress, lipid profile, insulin levels and changes in body weight. Treatment with antihyperglycemics and antioxidants are accounted to produce favorable effect in this paradigm. Fustin, a flavonoid derived from Rhus verniciflua, extract of Rhus verniciflua reported to exhibit anti-hyperglycemic, antioxidant, anti-microbial, anti-arthritic effects, anti-obesity effects, antiplatelet effects and anti-cancer effects. However, no evidence is existing on effect of fustin on STZ-induction diabetes. Thus, we evaluated its effects against diabetes in STZ-induced rodents. Blood glucose, Insulin, lipid peroxidation (MDA), superoxide dismutase (SOD), catalase activity (CAT), glutathione (GSH) and lipid profile levels was assessed. After 30 days diabetes induction rodents showed a severe increased blood sugar level, MDA, high density lipid and decreased cholestrol, triglyceride, GSH, SOD, CAT, respectively.Oppositely, treatment with fustin (50–100 mg/kg/p.o., two times daily, 30 days) enhanced blood glucose, lipid profile levels Insulin. Meanwhile, reduced MDA and enhanced GSH, SOD, and CAT in diabetic rats. Glibenclamide 5 mg/kg/p.o. also enhanced diabetes-induced complications and decreased oxidative stress. Further histopathology of pancreas confirms the protective effect fustin in STZ-induction diabetes in animals. In conclusion, the study revealed treatments with fustin avoid the changes in body weight, blood glucose, lipid profile and oxidative stress. As a results of these finding may lead to the growth of a choice of medicine for hyperglycemic in the future.
format article
author Sadaf Jamal Gilani
May Nasser Bin-Jumah
Fahad A. Al-Abbasi
Muhammad Shahid Nadeem
Muhammad Afzal
Nadeem Sayyed
Imran Kazmi
author_facet Sadaf Jamal Gilani
May Nasser Bin-Jumah
Fahad A. Al-Abbasi
Muhammad Shahid Nadeem
Muhammad Afzal
Nadeem Sayyed
Imran Kazmi
author_sort Sadaf Jamal Gilani
title Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes
title_short Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes
title_full Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes
title_fullStr Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes
title_full_unstemmed Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes
title_sort fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/superoxide dismutase/catalase expressions, suppress lipid peroxidation and regulates histopathological changes
publisher Elsevier
publishDate 2021
url https://doaj.org/article/84c949e613dd4f4fb92da3fed84cbc74
work_keys_str_mv AT sadafjamalgilani fustinameliorateshyperglycemiainstreptozotocininducedtype2diabetesviamodulatingglutathionesuperoxidedismutasecatalaseexpressionssuppresslipidperoxidationandregulateshistopathologicalchanges
AT maynasserbinjumah fustinameliorateshyperglycemiainstreptozotocininducedtype2diabetesviamodulatingglutathionesuperoxidedismutasecatalaseexpressionssuppresslipidperoxidationandregulateshistopathologicalchanges
AT fahadaalabbasi fustinameliorateshyperglycemiainstreptozotocininducedtype2diabetesviamodulatingglutathionesuperoxidedismutasecatalaseexpressionssuppresslipidperoxidationandregulateshistopathologicalchanges
AT muhammadshahidnadeem fustinameliorateshyperglycemiainstreptozotocininducedtype2diabetesviamodulatingglutathionesuperoxidedismutasecatalaseexpressionssuppresslipidperoxidationandregulateshistopathologicalchanges
AT muhammadafzal fustinameliorateshyperglycemiainstreptozotocininducedtype2diabetesviamodulatingglutathionesuperoxidedismutasecatalaseexpressionssuppresslipidperoxidationandregulateshistopathologicalchanges
AT nadeemsayyed fustinameliorateshyperglycemiainstreptozotocininducedtype2diabetesviamodulatingglutathionesuperoxidedismutasecatalaseexpressionssuppresslipidperoxidationandregulateshistopathologicalchanges
AT imrankazmi fustinameliorateshyperglycemiainstreptozotocininducedtype2diabetesviamodulatingglutathionesuperoxidedismutasecatalaseexpressionssuppresslipidperoxidationandregulateshistopathologicalchanges
_version_ 1718419724739543040